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OBJECTIVE—It is becoming apparent that there is a strong link
between taste perception and energy homeostasis. Recent evi-
dence implicates gut-related hormones in taste perception, in-
cluding glucagon-like peptide 1 and vasoactive intestinal peptide
(VIP). We used VIP knockout mice to investigate VIP’s speciﬁc
role in taste perception and connection to energy regulation.
RESEARCH DESIGN AND METHODS—Body weight, food
intake, and plasma levels of multiple energy-regulating hormones
were measured and pancreatic morphology was determined. In
addition, the immunocytochemical proﬁle of taste cells and
gustatory behavior were examined in wild-type and VIP knock-
out mice.
RESULTS—VIP knockout mice demonstrate elevated plasma
glucose, insulin, and leptin levels, with no islet -cell number/
topography alteration. VIP and its receptors (VPAC1, VPAC2)
were identiﬁed in type II taste cells of the taste bud, and VIP
knockout mice exhibit enhanced taste preference to sweet
tastants. VIP knockout mouse taste cells show a signiﬁcant
decrease in leptin receptor expression and elevated expression
of glucagon-like peptide 1, which may explain sweet taste
preference of VIP knockout mice.
CONCLUSIONS—This study suggests that the tongue can play
a direct role in modulating energy intake to correct peripheral
glycemic imbalances. In this way, we could view the tongue as a
sensory mechanism that is bidirectionally regulated and thus
forms a bridge between available foodstuffs and the intricate
hormonal balance in the animal itself. Diabetes 59:1143–1152,
2010
T
aste perception and its relationship to glucose
homeostasis begins with stimulation of taste
cells located in tongue taste buds. There are ﬁve
basic taste modalities: bitter, sweet, umami,
salty, and sour. Taste cells are clustered into taste buds in
the tongue epithelium (1). Mammals have four different
types of taste cells (types I, II, III, and IV), exhibiting
different molecular phenotypes and functional roles (2–4).
Type I cells are glial-like cells that maintain taste bud
structure. Type II taste cells transduce sweet, bitter, or
umami stimuli (5) and communicate information through
G-protein–coupled transduction cascades (6,7). Type III
cells synapse directly with afferent nerve ﬁbers from three
cranial nerves (8), and most release serotonin upon depo-
larization (9). Type IV “basal cells” are rapidly dividing
progenitor cells that differentiate into type I, II, and III
cells (10). Along with biogenic amine neurotransmitters, it
is becoming evident that multiple peptide hormones in-
cluding glucagon-like peptide-1 (GLP-1; [11]), cholecysto-
kinin (12), and neuropeptide Y (13) as well as VIP (14) are
located in taste cells, potentially acting as signaling mod-
ulators of multiple gustatory stimuli (15).
VIP is a 28–amino acid peptide expressed at multiple
sites throughout the body. It was discovered by its potent
muscle relaxant vasodilatory activity and as a stimulator
of secretory activity (16). VIP exerts its effects through
activation of two G-protein–coupled receptors (GPCRs):
VPAC1 and VPAC2 (17). These receptors preferentially
stimulate adenylate cyclase and increase intracellular
cAMP. VIP activity at VPAC1/2 receptors in pancreatic
islets is involved in insulin secretion (18). VIP expression
has been identiﬁed in the taste cells of rat, hamster, carp,
and human (12,14,19). In taste cells, VIP colocalizes with
the taste transduction markers -gustducin and T1R2 (20);
any role, however, of VIP in gustation has not previously
been established. Gustation is vital for locating food
sources and determining which foodstuffs to ingest. Gus-
tation is also involved in maintaining body weight and
energy balance, that is, there is a strong link between
peripheral somatic energy balance and “ﬂavor perception.”
This link may be mediated by the coherent use of a cadre
of neuropeptide hormones present in both the tongue and
the periphery. We have previously shown that the gut
incretin, GLP-1, in taste cells profoundly controls sweet
and umami taste (11,21). Peripheral leptin (food intake
regulator produced primarily in adipose tissue [22–24]),
via activation of the leptin receptor (Ob-Rb) on taste cells,
can inhibit responses to sweet tastants (25). Interestingly,
such selective sweet taste inhibition by peripheral leptin is
not present in leptin receptor–deﬁcient db/db mice (26–
28), suggesting that leptin, together with GLP-1, acts as a
dual-functional sweet-sensation modulator involved in the
regulation of food intake and somatic energy regulation.
In this study, we set out to uncover the role of VIP in
gustation. We demonstrate, using VIP knockout mice, that
VIP plays a speciﬁc role in modifying distinct taste modalities
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sion levels of other hormones and receptors that are involved
in the control of taste modulation and energy balance.
RESEARCH DESIGN AND METHODS
Animal and tissue processing. Animal testing procedures were approved by
the Animal Care and Use Committee of the National Institute on Aging.
Methods are described in detail in the supplementary material, available in
an online appendix at http://diabetes.diabetesjournals.org/cgi/content/full/
db09-0807/DC1.
Immunohistochemistry. Methods are described in detail in the supplemen-
tary material. Serial sections (10-m thickness) were cut from tissues
containing circumvallate, foliate, and fungiform papillae, using a cryostat
(Microm; Thermo Scientiﬁc). To obtain systematic samples without bias
throughout the papillae, each papilla was sectioned and every tenth section
was saved onto a slide. Taste buds are 80–100 m in length, therefore
sampling every tenth section ensures that no two sections will be from the
same taste bud. Images were collected using a confocal microscope LSM-710
(Carl Zeiss). Approximately 100–120 taste buds per group were analyzed
immunohistochemically as described previously (11,29). Only nuclear proﬁle–
positive cells were scored as immunoreactive. The total number of cells in the
section was determined by counting the number of TO-PRO-3–stained nuclei
present in each taste bud. The percentage of immunoreactive taste cells was
calculated by: number of immunoreactive taste cells/total number of taste
cells in each taste bud.
Immunoassay analyses of gut and appetite hormones in plasma. Plasma
levels of gut and appetite hormones were measured using a mouse multiplex
assay kit (Millipore) according to the manufacturer’s instructions. Methods
are described in detail in the supplementary material.
Pancreatic islet size quantiﬁcation and Western blot analyses. Methods
are described in detail in the supplementary material. Quantiﬁcation of
pancreatic immunohistochemistry images was performed in Matlab (Math-
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I FIG. 1. Expression of taste cell markers and VIP
in circumvallate papillae of wild-type (WT) and
VIP knockout (KO) mice. Type II cell marker
(PLC2) (A and B), type III cell marker (NCAM)
(C and D), and type IV cell marker (Shh) (E and
F) are expressed in taste cells of both wild-type
and VIP knockout mice. Scale bars, 20 m. Blue is
TO-PRO-3 nuclear stain. G and H: VIP (red) is
expressed in a subset of taste cells of wild-type
mice. I and J: VIP is not expressed within the VIP
knockout mouse taste bud. Scale bars, 20 m.
Sections are representative of three mice. (A
high-quality digital representation of this ﬁgure
is available in the online issue.)
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factors involved in energy regulation were determined by Western blot
analyses.
Taste behavioral tests. Taste behavioral testing was performed as previ-
ously described (11). VIP knockout and wild-type (n  8) mice were
habituated to the laboratory environment for 30 min each day prior to testing.
The same animals were used for both the taste behavioral tests and analyses
of physiological parameters (pancreatic function, gut/appetite plasma hor-
mone analyses). Test stimuli consisted of various concentrations of sucrose
(25, 75, 150, 300, and 600 mmol/l; Fisher Scientiﬁc), sodium chloride (NaCl:
100, 200, 400, 600, 800, and 1,000 mmol/l; Sigma), denatonium benzoate (0.001,
0.01, 0.1, 0.3, 1, 5, and 10 mmol/l; Sigma), and citric acid (0.01, 0.1, 1, 3, 5, 10,
30, and 100 mmol/l; Fisher Scientiﬁc). Brief-access taste testing took place in
a Davis MS-160 gustometer (DiLog Instruments) as previously described
(11,31–34). Brief-access procedures minimize postingestive effects that may
confound other assays such as intake tests (33). To test salty, sour, and bitter
stimuli responses, mice were water deprived prior to testing. For testing of the
sweet stimulus, mice were both food and water restricted (2.5 ml of water, 1 g
of food) prior to testing. All mice were tested with a single tastant at various
concentrations per trial, to prevent the mice from being affected by prior
experience. Data analysis is described in detail in the supplementary material.
RESULTS
VIP knockout mice possess normal taste bud mor-
phology. Gross taste bud morphology and taste cell
number were assessed in wild-type and VIP knockout mice
using classical taste cell type–speciﬁc immunocytochemi-
cal markers (supplementary Tables 1 and 2). Compared
with wild-type mice, VIP knockout mice showed no gross
taste bud abnormalities and expressed similar distribution
patterns of taste cell–speciﬁc markers (Fig. 1A–F, supple-
mentary Table 2). VIP immunoreactivity was present in the
taste cells of wild-type animals (Fig. 1G and H) but absent
in the VIP knockout mice (Fig. 1I and J). The lack of VIP,
therefore, did not signiﬁcantly affect initial taste cell
development and number.
VPAC1/2 receptors are expressed in taste cells. Both
VPAC1/2 receptors were primarily expressed in phospho-
lipase C2 (PLC2)-positive taste cells (type II cells: Fig. 2;
supplementary Figs. 2 and 3). The presence of VIP and its
cognate receptors in type II taste cells suggests that VIP
signaling is local to the taste bud and could likely affect
tongue-localized gustation.
Reduced leptin receptor and increased GLP-1 expres-
sion in VIP knockout mice taste cells. VIP is coex-
pressed with the taste transduction marker -gustducin
and with the T1R2 GPCR (20). The majority of VIP-
immunoreactive taste cells also coexpresses -gustducin,
although a subset also expresses T1R2. -Gustducin and
T1R2 are markers for type II cells, and based on this
speciﬁc expression pattern, we hypothesized that VIP
could be involved in the transduction of sweet and bitter
stimuli. To investigate this, we ﬁrst determined the expres-
sion patterns in the wild-type and VIP knockout mice of
additional hormones and receptors known to play a func-
tional role in sweet taste coding, that is, the T1R3 sweet
stimulant receptor, GLP-1, and leptin receptor (Ob-Rb)
(Fig. 3A–F). Both wild-type and VIP knockout mice
showed similar expression patterns of T1R3 in the circum-
vallate papillae (Fig. 3A, B, and G). Interestingly, we found
that GLP-1 expression was signiﬁcantly increased in the
taste cells of VIP knockout mice compared with wild type
(Fig. 3C, D, and G, P  0.001). Leptin receptor expression
was markedly reduced in VIP knockout mice compared
with wild type (Fig. 3E–G, P  0.001). Peripheral leptin
has been shown to suppress sweet taste preference
through its action on the leptin receptors in the taste
cells (26–28). Elevation in GLP-1 expression and the
reduction in leptin receptor expression strongly indi-
cates that VIP could play a role in modulating sweet
taste. Taken together, it is apparent that there are
signiﬁcant differences in the numbers of GLP-1– and
Ob-Rb–immunopositive cells between wild-type and VIP
knockout mice (Fig. 3G, supplementary Table 2). To
enhance our understanding of these alterations in the
taste cells of VIP knockout mice, we next determined
whether other systemic alterations in appetite/energy-
regulatory hormones occur in VIP knockout mice.
Elevation of plasma leptin and glucose in VIP knock-
out mice. As we detected reduced leptin receptor expres-
sion in VIP knockout mouse taste cells compared with
wild type, we measured plasma leptin levels in these mice.
Circulating leptin can bind to and activate the leptin
receptor on taste cells, where it acts to speciﬁcally inhibit
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FIG. 2. Coexpression of VIP receptors (VPAC1/VPAC2) and PLC2i n
circumvallate papillae of wild-type (WT) and VIP knockout (KO) mice.
A–C: VPAC1 (red) and PLC2 (green) are colocalized in a subset of
PLC2-positive cells (yellow cells) in wild-type mice. The arrows
denote cells expressing both. D–F: VPAC1 (red) and PLC2 (green) are
colocalized in a subset of PLC2-positive cells (yellow cells) in VIP
knockout mice. G–I: VPAC2 (red) and PLC2 (green) are colocalized in
a subset of PLC2-positive cells (yellow cells) in wild-type mice. The
arrows denote cells expressing both. J–L: VPAC2 (red) and PLC2
(green) are colocalized in a subset of PLC2-positive cells (yellow
cells) in VIP knockout mice. The arrows denote cells expressing both.
Scale bars, 20 m. Blue is TO-PRO-3 nuclear stain. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
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responses to sour, salty, and bitter substances in lean mice
(26–28). In VIP knockout mice, both nonfasting and fast-
ing glucose levels were elevated compared with wild type
(Fig. 4A and B). In addition, we noted a signiﬁcant
elevation in fasting insulin in VIP knockout mice com-
pared with wild type (Fig. 4C). We also found that plasma
leptin levels were signiﬁcantly elevated in VIP knockout
mice compared with wild type (Fig. 4D). These data
suggest that VIP knockout mice possess a diabetic-like
pathology. Plasma levels of amylin (Fig. 4E) were not
different between wild-type and VIP knockout mice,
whereas VIP knockout mice possessed considerably
higher plasma gastrointestinal polypeptide (Fig. 4F),
GLP-1 (Fig. 4G), and peptide tyrosine tyrosine (PYY) levels
(Fig. 4H). Plasma pancreatic polypeptide (PP) levels be-
tween wild-type and VIP knockout mice were not signif-
icantly different despite a trend for lower PP levels in
the VIP knockout mice (Fig. 4I).
VIP knockout mice have normal pancreatic islet
cell morphology. As VIP knockout mice possessed
signiﬁcantly elevated plasma insulin levels compared
with wild-type mice (P  0.01), we next investigated
pancreatic islet size and distribution of -cells and
-cells. VIP knockout mice showed similar total -cell
area compared with wild-type (Fig. 5A–C). No signiﬁ-
WT VIP KO
A
E
B
F
G
C D
PLCβ2 NCAM Shh T1R3 GLP-1 Leptin Receptor
0
5
10
15
20
25
30
35
40
45 VIP-WT
VIP-KO
%
 
o
f
 
i
m
m
u
n
o
-
r
e
a
c
t
i
v
e
 
T
C
s
**
***
13.97 ± 4.29%
T1R3 positive cells
14.16 ± 3.51%
T1R3 positive cells 
2.31 ± 1.42%
GLP-1 positive cells 
4.74 ± 1.75%
GLP-1 positive cells 
26.52 ± 4.83%
Leptin receptor
positive cells 
11.55 ± 3.97%
Leptin receptor
positive cells 
FIG. 3. Expression of taste-related proteins in circumvallate papillae of wild-type (WT) and VIP knockout (KO) mice. A and B: Sweet taste
receptor (T1R3, green) is expressed in both wild-type and VIP knockout mice. C and D: GLP-1 (green) is expressed in wild-type and VIP knockout
mice. E and F: Leptin receptor (green) is expressed in wild-type and VIP knockout mice. Scale bars, 20 m. Blue is TO-PRO-3 nuclear stain. G:
The percentage of immunopositive cells quantiﬁed in both wild-type and VIP knockout mice for the following markers: PLC2, NCAM, Shh, T1R3,
GLP-1, and leptin receptor. Cells were scored as immunoreactive only if a nuclear proﬁle was present within the cell. Values are the means  SEM.
**P < 0.01, ***P < 0.001. TCs, taste cells. (A high-quality digital representation of this ﬁgure is available in the online issue.)
VASOACTIVE INTESTINAL PEPTIDE AND GUSTATION
1146 DIABETES, VOL. 59, MAY 2010 diabetes.diabetesjournals.orgcant difference in the total percentage of -o r-cells in
the islets (Fig. 5D) and the number of small-, middle-,
and large-sized islets between wild-type and VIP knock-
out mice was observed (Fig. 5E).
VIP in taste cells regulates multiple taste modalities.
As a considerable amount of our molecular/immunocyto-
chemical data suggested a role for VIP in taste modulation,
we next investigated VIP’s role in taste perception. We
tested the ability of wild-type and VIP knockout mice to
detect prototypical taste stimuli, that is, sweet (sucrose),
sour (citric acid), salty (sodium chloride), and bitter
(denatonium benzoate). VIP knockout mice displayed sig-
niﬁcantly altered concentration-dependent licking for su-
crose (P  0.0108 between mean half-maximal effective
concentration [EC50] values) and denatonium benzoate
(P  0.0003 between mean EC50 values) compared with
wild-type mice, demonstrated by their lower EC50 values
compared with wild type (Fig. 6A and C, supplementary
Fig. 1). VIP knockout mice also showed concentration-
dependent changes in licking for citric acid (P  0.023
between mean EC50 values) (Fig. 6B), but there was no
signiﬁcant alteration for sodium chloride in the VIP knock-
out mice compared with wild-type mice (Fig. 6D). Taken
together, these results indicate that VIP plays a speciﬁc
functional role in modulating taste perception of sweet,
bitter, and sour stimuli.
VIP knockout mice attempt to ameliorate their dys-
glycemia. Our data indicate that there is an alteration in
the biochemical, but not structural, nature of the tongue of
VIP knockout mice, as well as complex alterations in
circulating metabolic hormones. One paradoxical ﬁnding,
however, was the reduction in leptin receptor levels in the
tongue. VIP knockout mice demonstrate several features
reminiscent of insulin resistance (e.g., high fasting glucose
and insulin levels). In addition, VIP knockout animals
possessed a heightened preference for appetitive sweet
stimuli. Perhaps this change in taste preference—induced
by increased tongue GLP-1 levels and reduced leptin
receptor levels—could be a compensatory mechanism
engendered to ameliorate their dysglycemia by attempting
to reduce sugar intake. High circulating levels of leptin
would be expected to reduce sweet taste preference (25),
but with a signiﬁcant ablation of the lingual Ob-Rb, this
would be prevented. However, if this Ob-Rb ablation was
universal, especially in the hypothalamus, then the animal
would likely consume even more food and thus exacerbate
its dysglycemic state. We, therefore, assessed the expres-
sion level of Ob-Rb in the hypothalami of wild-type and
VIP knockout mice. In contrast to the tongue, no differ-
ence in Ob-Rb expression between wild-type and VIP
knockout hypothalami was observed (Fig. 7A and B). In
addition, we found no difference in insulin receptor sub-
strate 2 (IRS2), T1R3 receptor, or GLP-1 expression in the
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FIG. 4. VIP knockout (KO) mice possess alterations in multiple hormones controlling appetite and energy balance. Multiplex hormone analysis
from plasma samples of wild-type (WT) and VIP knockout mice reveal multiple distinctions between the two animal groups. A and B: Signiﬁcantly
higher nonfasting and fasting glucose occurs in the VIP knockout mice. The VIP knockout mice also possessed signiﬁcantly higher plasma insulin
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and C–E). VIP knockout mice showed a small reduction in
food intake compared with wild-type mice (Fig. 7F) and
there was no signiﬁcant difference in body weight between
VIP knockout and wild-type mice (Fig. 7G). Thus, it
appears that the VIP knockout mice possess a complex
physiological reaction to the imposed loss of VIP, one that
may, in part, attempt to ameliorate their dysglycemia. VIP
knockout mice show an increase in sweet taste preference
and have elevated circulating leptin levels, which together
could potentially be a mechanism to prevent additional
excessive sugary food intake (summarized in Fig. 8).
However, this mechanism would succeed only if there was
localized lingual loss of the Ob-Rb, which was observed in
the VIP-null mice.
DISCUSSION
We have demonstrated that VIP knockout mice possess
alterations in their taste cells, circulating metabolic hor-
mones, and taste preferences. Together, these factors
appear to contribute to a unique dysglycemic pathophysi-
ology. VIP and its cognate receptors are expressed in the
type II taste cells of the circumvallate papillae. VIP knock-
out mice demonstrated normal gross taste bud morphol-
ogy (Figs. 1 and 2). However, several key biochemical and
pharmacologic alterations in their tongues were seen, that
is, VIP knockout compared with wild-type mice exhibited
signiﬁcant increases and decreases in GLP-1 and leptin
receptor, respectively, in taste cells (Fig. 3). In light of our
previous ﬁndings that GLP-1 in taste cells enhances sweet
taste perception, this strongly indicated to us that taste
cell VIP signaling may be involved in sweet taste percep-
tion. We demonstrated that VIP knockouts possess a
greater preference for sweet compounds compared with
wild-type mice (Fig. 6). VIP knockout mice also exhibited
concentration-dependent changes in licking bitter stimuli
and sour stimuli, but there was no change in salt percep-
tion compared with wild-type mice.
It is interesting to note that VPAC1/2 receptors were
expressed on type II taste cells. Receptor systems respon-
sive to bitter, sweet, and umami stimuli use similar signal
transduction systems that themselves are narrowly tuned
and achieve functional speciﬁcity by expression in non-
overlapping subsets of type II cells. Interestingly, in this
study, compared with our previous study (11), both VIP
knockout and wild-type mice presented much higher su-
crose/water lick ratios than GLP-1 receptor knockout
(GLP-1R knockout) mice and their wild-type controls. It is
unsurprising that distinct strains of mice possess different
tastant responses, and this observation may be important
for future experimental consideration of speciﬁc strains to
facilitate efﬁcient and sensitive detection of alterations in
different taste modalities.
One unexpected ﬁnding in our VIP knockout mice was
the signiﬁcant reduction in leptin receptor (Ob-Rb) expres-
sion in the taste cells (Fig. 3F and G). Circulating leptin
can activate leptin receptors on taste cells and speciﬁcally
inhibit gustatory responses to sweet compounds (25).
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tor expression in VIP knockout mice may, in part, account
for their heightened preference for sweet tastants. Loss of
the Ob-Rb would reduce any inhibitory action that circu-
lating leptin would have upon sweet taste. This ﬁnding was
interesting in light of our data showing that circulating
levels of leptin in VIP knockout mice were considerably
higher than those in wild type. Therefore, despite the
presence of high concentrations of this sweet taste sup-
pressor, the reduction of taste cell leptin receptor was able
to facilitate enhanced sweet sensation by preventing in-
hibitory leptin signaling activity in the tongue. The ele-
vated sweet preference of the VIP knockout mice may also
stem from the elevated levels of taste cell GLP-1. We have
previously shown that GLP-1’s ability to activate the
GLP-1R in the tongue strongly modulates sweet taste in
mice (11). Increased levels of GLP-1 could, therefore,
potentiate GLP-1R activity in the tongue, especially con-
sidering our previous ﬁndings that the enzyme that de-
grades GLP-1 in the peripheral circulation (dipeptidyl
peptidase-4) is not present in taste cells of mice (11). The
precise temporal nature of Ob-Rb loss, peripheral increase
in leptin levels, or elevations in taste cell GLP-1 remains to
be determined, but our data suggest that there is a strong
connection between peripheral energy–regulatory hor-
mones and lingual preference for foodstuffs. From our
data, this physiological link may involve VIP. Because of
the multiple sites and mechanisms of action of VIP in
mammals, it is unsurprising that the metabolic phenotype
of VIP knockout mice is complex. Hence, despite in-
creased leptin and PYY levels in VIP knockout mice
there was no dramatic diminution of body weight or
food intake. This may, in part, be due to removal of an
inhibitory action of VIP upon food intake, demonstrated
in multiple species including mice (35). Therefore, the
resultant phenotype of the VIP knockout mice may be
truly an intricate mixture of alterations of metabolic
food desire and digestion.
In our study, several lines of evidence indicate a strong
local taste cell action of VIP. First, VIP knockout mice
demonstrated concentration-dependent changes in licking
for sweet, bitter, and sour tastants, but not salt, indicating
that there was not a generalized, widespread positive
effect on all taste modalities. Second, VIP knockout and
wild-type mice responded similarly to the salty taste
stimulus; therefore, VIP knockout mice had no difﬁculty in
learning and completing the taste test. Lastly, VIP and VIP
receptors are speciﬁcally localized within sweet- and
bitter-sensitive taste cells, consistent with the speciﬁc
taste alterations we observed. Further reinforcing a selec-
tive local action of VIP, we found no VIP immunoreactivity
in type I cells. It has been demonstrated that amiloride-
sensitive Na
 channels are expressed in type I cells of the
fungiform papillae, suggesting that these taste cells could
play a role in transducing salty taste stimuli (36). In line
with this ﬁnding, we found that there was no difference in
salt perception between VIP knockout and wild-type mice.
Thus, it would be reasonable to propose that VIP signaling
in the taste bud plays a local role in modulating sweet,
bitter, and sour taste stimuli.
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may affect both sweet and bitter stimuli. Sweet and bitter
signal transduction is commonly mediated by PLC mech-
anisms involving taste receptor activation, as well as
through adenylate cyclase–dependent mechanisms.
VPAC1/2 receptors are coupled to multiple G-protein
effectors to activate phospholipase D, PLC, and adenyl-
ate cyclase. VIP stimulation of VPAC receptors would
therefore likely compete for availability of the PLC and
adenylate cyclase signaling pathways, potentially diluting
the functional signal transduction efﬁcacy of the primary
taste receptors. We have previously demonstrated that
receptor stimulation of multiple related receptor systems
can result in strong inhibitory effects that are profound
and long-lasting (37). Genetic removal of the stimulating
ligand will result in a diminution in the number of active
VPAC1/2 receptors, reducing any diluting competitive ac-
tions upon the taste receptor’s signaling capacity. Future
experimentation upon the signaling efﬁciency of taste
receptors in such an environment may shed light on this
hypothesis.
The ability of VIP ablation to affect not only sweet and
bitter taste perception, but also the response to a sour
stimulus may be, in part, due to a role of VIP in controlling
cell-cell signaling between taste cells and the type III
(“presynaptic”) cells possessing the putative sour receptor
(PKD2L1). Recent data have shown that although presyn-
aptic cells do not possess tastant-sensitive GPCRs (38),
they still respond to tastant stimulation (5). Communica-
tion between taste cells and presynaptic cells is thought to
involve ATP and serotonin secretion from the taste cells
(39). In many areas of the gut, VIP is coreleased with both
ATP and nitric oxide (NO) to exert relaxatory effects on
smooth muscle (40). NO is commonly secreted from
postsynaptic nervous tissue to act upon presynaptic neu-
rons to control neurotransmitter release, and NO has also
been associated with taste transduction (41). Therefore, it
may be possible that in the tongue VIP may act in an
analogous manner as in other parts of the digestive tract
(i.e., in a concerted manner with NO and ATP). Therefore,
genetic disruption of VIP may affect efﬁcient taste cell–
presynaptic cell communication, resulting in the reduction
in sour taste we observed in VIP knockout mice.
We have demonstrated a complex physiological pattern
of changes in VIP knockout mice that superﬁcially may
seem unconnected but together form a coherent and
rational reactive mechanism to maintain energy homeosta-
sis. VIP knockout animals demonstrate signiﬁcantly ele-
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signiﬁcantly higher levels of circulating leptin but a strik-
ing reduction in Ob-Rb expression in the taste cells, while
maintaining normal levels of Ob-Rb and other energy-
regulatory factors (GLP-1, T1R3) in the hypothalamus. In
addition, the animals demonstrate an altered preference
for sweet tastants. The loss of VIP in our mice induces a
dysglycemic state, that is, high resting glucose paired with
a high insulin level. With knockout animals that survive
birth, it is likely that they have physiologically adapted to
counteract their deﬁcits. For example, the lack of alter-
ation of islet -cell mass in the VIP knockout mice may be
compensated for by the nonselective activity of structur-
ally similar peptides, for example, pituitary adenylate
cyclase activating polypeptide, which can activate VPAC2
receptors in the VIP knockout pancreata, substituting for
VIP activity (18).
It would be interesting to speculate that reactive actions
in VIP knockout mice have attempted to ameliorate their
diabetic-like pathology by increasing their sweet prefer-
ence (through reduced inhibitory leptin receptor activity
and increased GLP-1 expression in the tongue) so as not to
overconsume carbohydrates, while also trying to dampen
their overall appetite (increased peripheral circulating
leptin with normal hypothalamic Ob-Rb expression) (Fig.
8). Central nervous system VIP is antagonistic to dopa-
mine and serotonin nervous activity (42,43). Both of these
transmitters control food reward responses (44,45), and
therefore VIP knockout mice may possess an elevated
reward response, curtailing their intake and preventing
weight increases. Human analogy of VIP knockout mice
may be seen in “supertasters” (possessing increased sweet
and bitter sensitivity) who tend to be more lean and
perhaps eat less than nonsupertasters (46). However, it is
unclear whether the VIP knockout mice would not have
gained weight if their chow was sweetened with sucrose,
and more studies are needed to explore this further.
Thus, an interesting hypothesis would be that these
multiple concerted responses in the VIP knockout mice
suggest that the tongue could potentially act as a vessel
for the animal to modulate its energy intake to correct
any endogenous glycemic imbalances. In this way, we
could potentially view the tongue as a sensory mecha-
nism that is bidirectionally regulated, and thus forms a
bridge between available foodstuffs and the intricate
metabolic hormonal balance in the animal itself. Future
studies would be needed to further explore this
hypothesis.
To conclude, it is becoming apparent that there is a
strong link between gustation and peripheral energy bal-
ance. Hormonal signaling within the taste buds of the
tongue is likely to inﬂuence food intake and peripheral
glucose homeostasis (15). For example, hormones such as
GLP-1 and leptin, crucial to the control of peripheral
somatic energy balance/appetite, are now thought to exert
a strong local effect on the tongue with respect to food
perception. This activity is mediated by their signaling
roles in the gustatory system. Carbohydrates are among
the most vital food stuffs for mammalian survival, and it
would make evolutionary sense for mammals to have
evolved multimodal carbohydrate sensing mechanisms.
We feel that gaining a greater appreciation for which
endocrine factors are present within taste cells and their
putative roles in taste perception will shed much-needed
light on how taste perception is linked to peripheral
somatic energy balance. This knowledge will be invaluable
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FIG. 8. A diagrammatic summary of the complex physiological parameters observed in the VIP knockout (KO) mice compared with the wild-type
(WT) controls. The VIP knockout mice present with a diabetic-like state, and they actively attempt to ameliorate this condition with a series of
physiological alterations (high circulating leptin, low tongue Ob-Rb expression, high tongue GLP-1 expression, normal hypothalamic Ob-Rb
expression) that—in concert—could attenuate the animals’ euglycemic disruption by enhancing their sweet taste and potentially reducing their
desire to consume sweet foods.
B. MARTIN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, MAY 2010 1151for ﬁnding novel therapeutic targets and agents for the
treatment of disorders such as metabolic syndrome and
type 2 diabetes.
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